有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(2,3-dihydro-1-benzothiophen-5-yl)-1,3-thiazol-4-amine | —— | C11H10N2S2 |
|
—— | [(1R)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl] 2-(2,4-dimethylphenyl)sulfanylacetate | —— | C20H20N2O3S |
|
—— | [(1S)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl] 2-(2,4-dimethylphenyl)sulfanylacetate | —— | C20H20N2O3S |
|
—— | 1-[(2S)-2-hydroxy-2-thiophen-3-ylpropyl]-3-[(4-methylsulfanylphenyl)methyl]urea | —— | C16H20N2O2S2 |
|
—— | 1-[(2R)-2-hydroxy-2-thiophen-3-ylpropyl]-3-[(4-methylsulfanylphenyl)methyl]urea | —— | C16H20N2O2S2 |
|
—— | N-[(2S)-2-(dimethylamino)-2-thiophen-2-ylethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C12H16N4OS3 |
|
—— | N-[(2R)-2-(dimethylamino)-2-thiophen-2-ylethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C12H16N4OS3 |
|
—— | 2-(3,4-Dimethylphenyl)-5-[(5-methyl-1,2-oxazol-3-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C15H15N3O2S |
|
—— | 1-[(6R)-6-(hydroxymethyl)-1,4-oxazepan-4-yl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]ethanone | —— | C12H18N2O3S2 |
|
—— | 1-[(6S)-6-(hydroxymethyl)-1,4-oxazepan-4-yl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]ethanone | —— | C12H18N2O3S2 |
|
—— | (6R)-6-[(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethylamino)methyl]-1,4-oxazepan-6-ol | —— | C12H20N4O2S |
|
—— | [(2S)-1-(4-acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-1-oxopropan-2-yl] (2R)-2-(4-methylphenyl)sulfanylpropanoate | —— | C21H25NO4S |
|
—— | (2S)-2-[(4-amino-1,2,4-triazol-3-yl)sulfanyl]-N-[(4-fluorophenyl)methyl]propanamide | —— | C12H14FN5OS |
|
—— | 5-methyl-3-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole | —— | C11H10N4OS2 |
|
—— | (2R)-N-methyl-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]-N-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]propanamide | —— | C15H21N5O3S |
|
—— | (2S)-N-methyl-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]-N-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]propanamide | —— | C15H21N5O3S |
|
—— | (3S)-3-[[2-(1-methylimidazol-2-yl)sulfanylethylamino]methyl]piperidin-3-ol | —— | C12H22N4OS |
|
—— | (3R)-3-[[2-(1-methylimidazol-2-yl)sulfanylethylamino]methyl]piperidin-3-ol | —— | C12H22N4OS |
|
—— | (6S)-6-[(2-pyridin-2-ylsulfanylethylamino)methyl]-1,4-oxazepan-6-ol | —— | C13H21N3O2S |
|
—— | (6R)-6-[(2-pyridin-2-ylsulfanylethylamino)methyl]-1,4-oxazepan-6-ol | —— | C13H21N3O2S |
|
—— | [4-(4-Methoxyphenyl)sulfanylphenyl]urea | —— | C14H14N2O2S |
|
—— | [(6R)-4-[(2-propylsulfanylpyrimidin-5-yl)methyl]-1,4-oxazepan-6-yl]methanol | —— | C14H23N3O2S |
|
—— | [(6S)-4-[(2-propylsulfanylpyrimidin-5-yl)methyl]-1,4-oxazepan-6-yl]methanol | —— | C14H23N3O2S |
|
—— | 2-(4-fluorophenyl)sulfanyl-N-[[5-(2-methyl-1,3-thiazol-4-yl)thiophen-2-yl]methyl]acetamide | —— | C17H15FN2OS3 |
|
—— | (3S)-3-[2-[5-(4-methylphenyl)sulfanylfuran-2-yl]imidazol-1-yl]pyrrolidin-2-one | —— | C18H17N3O2S |
|
—— | (3R)-3-[2-[5-(4-methylphenyl)sulfanylfuran-2-yl]imidazol-1-yl]pyrrolidin-2-one | —— | C18H17N3O2S |
|
—— | (2R)-2-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(4-fluorophenyl)methyl]propanamide | —— | C16H20FN3OS3 |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-[[4-methyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C11H15F3N4O3S2 |
|
—— | methyl N-[(2S)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]propanoyl]carbamate | —— | C9H12N2O3S2 |
|
—— | (2S)-2-pyridin-2-ylsulfanyl-1-[4-(thiophen-2-ylmethyl)-1,4-diazepan-1-yl]propan-1-one | —— | C18H23N3OS2 |
|
—— | (2R)-2-pyridin-2-ylsulfanyl-1-[4-(thiophen-2-ylmethyl)-1,4-diazepan-1-yl]propan-1-one | —— | C18H23N3OS2 |
|
—— | (4R)-N-[2-(1-methylimidazol-2-yl)sulfanylethyl]-1,9-dioxaspiro[5.5]undecan-4-amine | —— | C15H25N3O2S |
|
—— | (4S)-N-[2-(1-methylimidazol-2-yl)sulfanylethyl]-1,9-dioxaspiro[5.5]undecan-4-amine | —— | C15H25N3O2S |
|
—— | (6S)-4-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]-1,4-oxazepan-6-ol | —— | C13H18N4O3S |
|
—— | (6R)-4-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]-1,4-oxazepan-6-ol | —— | C13H18N4O3S |
|
—— | 5-[(2S)-1-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]pyrrolidin-2-yl]-3-propan-2-yl-1,2,4-oxadiazole | —— | C17H22N6O2S |
|
—— | 5-[(2R)-1-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]pyrrolidin-2-yl]-3-propan-2-yl-1,2,4-oxadiazole | —— | C17H22N6O2S |
|
—— | (3R)-3-(piperidin-1-ylmethyl)-1-[(2-propylsulfanylpyrimidin-5-yl)methyl]pyrrolidin-3-ol | —— | C18H30N4OS |
|
—— | 4-methyl-2-methylsulfanyl-6-[4-[(1S)-1-pyrrolidin-1-ylethyl]piperidin-1-yl]pyrimidine | —— | C17H28N4S |
|
—— | 4-methyl-2-methylsulfanyl-6-[4-[(1R)-1-pyrrolidin-1-ylethyl]piperidin-1-yl]pyrimidine | —— | C17H28N4S |
|
—— | (3S)-3-(piperidin-1-ylmethyl)-1-[(2-propylsulfanylpyrimidin-5-yl)methyl]pyrrolidin-3-ol | —— | C18H30N4OS |
|
—— | (3S)-1-[1-(6-methyl-2-methylsulfanylpyrimidin-4-yl)piperidin-4-yl]piperidin-3-ol | —— | C16H26N4OS |
|
—— | (3R)-1-[1-(6-methyl-2-methylsulfanylpyrimidin-4-yl)piperidin-4-yl]piperidin-3-ol | —— | C16H26N4OS |
|
—— | (6S)-6-[[2-(2H-triazol-4-ylsulfanyl)ethylamino]methyl]-1,4-oxazepan-6-ol | —— | C10H19N5O2S |
|
—— | (6R)-6-[[2-(2H-triazol-4-ylsulfanyl)ethylamino]methyl]-1,4-oxazepan-6-ol | —— | C10H19N5O2S |
|
—— | 3-(N-methyl-4-propan-2-ylsulfanylanilino)propanoic acid | —— | C13H19NO2S |
|
—— | (2R)-2-amino-2-(4-cyclopentylsulfanylphenyl)propan-1-ol | —— | C14H21NOS |
|
—— | (2S)-2-amino-2-(4-cyclopentylsulfanylphenyl)propan-1-ol | —— | C14H21NOS |
|
—— | N,2-dimethyl-4-(4-propan-2-ylsulfanylphenyl)butan-2-amine | —— | C15H25NS |
|
—— | (S)-(1-methylpiperidin-4-yl)-(4-methylsulfanylphenyl)methanamine | —— | C14H22N2S |
|